FUDAN FORWARD(SH:600624) Zhong Guo Zheng Quan Bao·2025-09-20 10:11Core Viewpoint - Fudan Fuhua has received a notice of administrative penalty from the Shanghai Securities Regulatory Commission (SSRC) for suspected false disclosures in its annual reports for 2019, 2020, and 2023, leading to warnings and fines for the company and related individuals [1][5][7]. Group 1: Administrative Penalty - The SSRC has proposed to issue a warning and impose a fine of 4 million yuan on the company [7]. - Key individuals involved in the violations will also face penalties, including 1 million yuan for Zhao Wenbin, 500,000 yuan for Chu Jianping, and 700,000 yuan for Zhao Zhenxing [7]. - The company has stated that it has completed rectifications regarding the issues mentioned in the SSRC's notice [8]. Group 2: Financial Discrepancies - The 2019 annual report understated operating costs by 50.65 million yuan, inflating total profits by the same amount, which accounted for 60.25% of the reported profit for that year [5]. - The 2020 annual report understated operating costs by 2.59 million yuan, inflating total profits by 2.59 million yuan, representing 7.11% of the reported profit [5]. - The 2023 annual report allegedly understated asset impairment losses by 27.82 million yuan, inflating total profits by 27.82 million yuan, which constituted 118.48% of the reported profit for that year [5]. Group 3: Stock Market Impact - Following the SSRC's notice, the company's stock will be subject to risk warnings, changing its A-share abbreviation to "ST Fuhua," with a daily price fluctuation limit of 5% [3]. - The stock was reported at 7.02 yuan per share on September 19, with a decline of 3.57% [4]. Group 4: Business Performance - In the first half of 2025, the company reported revenue of 326 million yuan, a year-on-year increase of 2.20%, but a net loss of 7.12 million yuan, continuing a trend of losses [9]. - The pharmaceutical segment generated 147 million yuan in revenue, a decrease of 7.57%, accounting for 45% of total revenue [9]. Group 5: Management Changes - Recent resignations include the vice president Zhou Chihao and the securities representative Yu Zhibin, both citing personal reasons for their departures [10].